SitesBLAST
Comparing WP_090273468.1 NCBI__GCF_900105005.1:WP_090273468.1 to proteins with known functional sites using BLASTp with E ≤ 0.001.
Or try Sites on a Tree, PaperBLAST, Conserved Domains, or compare to all protein structures
Found 15 hits to proteins with known functional sites (download)
Q8NLB7 Gentisate transporter from Corynebacterium glutamicum (strain ATCC 13032 / DSM 20300 / JCM 1318 / BCRC 11384 / CCUG 27702 / LMG 3730 / NBRC 12168 / NCIMB 10025 / NRRL B-2784 / 534) (see paper)
25% identity, 90% coverage: 18:423/451 of query aligns to 39:412/444 of Q8NLB7
- D54 (≠ E30) mutation to A: Loss of transport activity.; mutation to E: Retains 50% of its transport activity.
- D57 (= D33) mutation to A: Loss of transport activity.; mutation to E: Retains 50% of its transport activity.
- R103 (≠ K86) mutation to A: Loss of transport activity.
- W309 (≠ L316) mutation to V: Loss of transport activity.
- D312 (= D322) mutation to A: Loss of transport activity.
- R313 (= R323) mutation to A: Loss of transport activity.
- I317 (vs. gap) mutation I->H,Y: Loss of transport activity.
- R386 (≠ S398) mutation to A: Loss of transport activity.
P36035 Carboxylic acid transporter protein homolog from Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) (see paper)
27% identity, 75% coverage: 67:405/451 of query aligns to 182:508/616 of P36035
- K338 (= K239) modified: Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)
Sites not aligning to the query:
- 1 modified: Initiator methionine, Removed
- 9 modified: Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)
A0A0H2VG78 Glucose transporter GlcP; Glucose/H(+) symporter from Staphylococcus epidermidis (strain ATCC 12228 / FDA PCI 1200) (see paper)
26% identity, 79% coverage: 43:399/451 of query aligns to 30:382/446 of A0A0H2VG78
- R102 (= R128) mutation to A: Loss of transport activity.
- I105 (≠ Q131) mutation to S: Affects symport activity. May function as an uniporter.
- E122 (= E148) mutation to A: Loss of transport activity.
- Q137 (= Q163) mutation to A: Loss of transport activity.
- Q250 (vs. gap) mutation to A: Loss of transport activity.
- Q251 (vs. gap) mutation to A: Loss of transport activity.
- N256 (≠ T263) mutation to A: Loss of transport activity.
- W357 (≠ G374) mutation to A: Loss of transport activity.
Sites not aligning to the query:
- 22 D→N: Affects symport activity. May function as an uniporter.
O15244 Solute carrier family 22 member 2; Organic cation transporter 2; hOCT2 from Homo sapiens (Human) (see 8 papers)
24% identity, 77% coverage: 75:423/451 of query aligns to 162:499/555 of O15244
- M165 (≠ V78) to I: lower Vmax for MPP(+) transport; no change in transport efficiency (Vmax/Km) and clearance of cyclo(his-pro) and salsolinol; dbSNP:rs8177507
- Y169 (≠ H82) mutation to F: No change in TEA uptake.
- T201 (≠ G117) to M: in dbSNP:rs145450955
- Y241 (≠ P162) mutation to F: Slight decrease in TEA uptake. No change in tyrosine phosphorylation. Strong decrease in TEA uptake; when associated with F-362. Strong decrease in TEA and metformin uptake and YES1-mediated tyrosine phosphorylation; when associated with F-362 and F-377.
- Y257 (≠ A182) mutation to F: No change in TEA uptake.
- S270 (= S190) to A: decreased Ki value for TBA inhibition of MPP(+); no change in transport efficiency (Vmax/Km) and clearance of cyclo(his-pro) and salsolinol; dbSNP:rs316019
- Y279 (≠ W199) mutation to F: No change in TEA uptake.
- Y280 (≠ G200) mutation to F: No change in TEA uptake.
- P284 (= P204) mutation to A: Decreased TEA and metformin uptake. Decreased tyrosine phosphorylation.
- PESPR 284:288 (≠ P---- 204) Proline-rich sequence
- S286 (vs. gap) mutation to A: No change in TEA and metformin uptake. No change in tyrosine phosphorylation.
- P287 (vs. gap) mutation to A: Decreased TEA and metformin uptake. Decreased tyrosine phosphorylation.
- Y362 (= Y277) mutation to F: Decreased TEA uptake and YES1-mediated tyrosine phosphorylation. Strong decrease in TEA uptake; when associated with F-241. Strong decrease in TEA uptake; when associated with F-377. Strong decrease in TEA and metformin uptake and YES1-mediated tyrosine phosphorylation; when associated with F-241 and F-377.
- Y377 (≠ V300) mutation to F: Slight decrease in TEA uptake. No change in tyrosine phosphorylation. Strong decrease in TEA uptake; when associated with F-362. Strong decrease in TEA and metformin uptake and YES1-mediated tyrosine phosphorylation; when associated with F-241 and F-362.
- R400 (= R323) to C: lower Vmax and reduced Ki value for TBA inhibition of MPP(+); lower transport efficiency (Vmax/Km) and clearance of cyclo(his-pro); no change in transport efficiency (Vmax/Km) and clearance of salsolinol; dbSNP:rs8177516
- K432 (≠ I360) to Q: lower Km value for MPP(+) and reduced Ki value for TBA inhibition of MPP; no change in transport efficiency (Vmax/Km) and clearance of cyclo(his-pro) and salsolinol; dbSNP:rs8177517
- Y458 (≠ F381) mutation to F: No change in TEA uptake.
Sites not aligning to the query:
- 54 P → S: in dbSNP:rs8177504
- 73 Y→F: No change in TEA uptake.
- 92 Y→F: No change in TEA uptake.
- 128 Y→F: No change in TEA uptake.
- 544 Y→F: No change in TEA uptake.
8bvtA Cryo-em structure of rat slc22a6 bound to probenecid (see paper)
22% identity, 76% coverage: 70:410/451 of query aligns to 133:462/508 of 8bvtA
Sites not aligning to the query:
8bvsA Cryo-em structure of rat slc22a6 bound to tenofovir (see paper)
22% identity, 76% coverage: 70:410/451 of query aligns to 124:453/502 of 8bvsA
Q9R0W2 Solute carrier family 22 member 2; Organic cation transporter 2; rOCT2 from Rattus norvegicus (Rat) (see paper)
22% identity, 74% coverage: 75:408/451 of query aligns to 162:484/555 of Q9R0W2
- C451 (≠ G374) Involved in recognition of organic cations and participates in structural changes that occur during translocation of organic cations; mutation to M: Transport activity strongly reduced.
Q7KWJ5 Hexose transporter 1; PfHT1 from Plasmodium falciparum (isolate 3D7) (see 5 papers)
22% identity, 87% coverage: 3:393/451 of query aligns to 6:431/504 of Q7KWJ5
- N48 (≠ A38) mutation to A: Reduces D-glucose and D-fructose transport activity.
- K51 (≠ A41) mutation to A: Reduces D-glucose and D-fructose transport activity. Reduces susceptibility to inhibition by compound HTI-1. Reduces susceptibility to inhibition by compound HTI-1; when associated with A-447.; mutation to Q: Reduces D-glucose and D-fructose transport activity.
- C61 (≠ P51) modified: Disulfide link with 70
- C70 (≠ E55) modified: Disulfide link with 61
- H168 (≠ P162) mutation to N: Reduces D-glucose and D-fructose transport activity.
- Q169 (= Q163) binding alpha-D-glucose; binding beta-D-glucose; mutation to A: Abolishes D-glucose and D-fructose transport activity.; mutation to N: In one study, shown to abolish D-glucose and D-fructose transport activity. In another study, shown to abolish D-fructose transport with no significant effects on D-glucose uptake and affinity. Reduces susceptibility to inhibition by compound 3361.
- S302 (≠ Y277) mutation to A: No significant effects on affinity for D-glucose and D-fructose.
- SGL 302:304 (≠ YGR 277:279) mutation to AGT: No significant effects on affinity for D-glucose and D-fructose.
- L304 (≠ R279) mutation to T: No significant effects on affinity for D-glucose and D-fructose.
- Q305 (≠ A280) binding alpha-D-glucose; binding beta-D-glucose; mutation to A: Reduces D-glucose and D-fructose transport activity.
- Q306 (≠ P281) binding alpha-D-glucose; mutation to A: Reduces D-glucose and D-fructose transport activity.
- I310 (≠ A285) mutation to A: Reduces D-glucose and D-fructose transport activity.
- N311 (≠ A286) binding alpha-D-glucose; binding beta-D-glucose; mutation to A: Reduces D-glucose and D-fructose transport activity.
- V314 (≠ L289) mutation to F: Reduces D-glucose and D-fructose transport activity.
- S315 (= S290) mutation to A: No significant effects on D-glucose and D-fructose transport activities. Reduces turnover number for D-glucose.; mutation to Y: Reduces D-glucose and D-fructose transport activity.
- N316 (≠ G291) mutation N->A,Y: Reduces D-glucose and D-fructose transport activity.
- S317 (≠ L292) mutation to A: Reduces D-glucose and D-fructose transport activity.
- N318 (≠ G293) mutation to A: Reduces D-glucose and D-fructose transport activity.
- E319 (≠ Y294) mutation to A: No significant effects on D-glucose and D-fructose transport activities. Reduces turnover number for D-glucose.
- N341 (≠ F313) binding beta-D-glucose; mutation to A: Abolishes D-glucose and D-fructose transport activity.
- F403 (= F363) mutation to A: Reduces D-glucose and D-fructose transport activity.
- A404 (≠ S364) mutation to E: Modestly reduces D-glucose and D-fructose transport activities and affinities for these substrates.
- W412 (≠ G374) binding alpha-D-glucose; mutation to A: Reduces D-fructose transport with no significant effect on D-glucose uptake.
Sites not aligning to the query:
- 435 N→A: Reduces D-fructose transport with no significant effect on D-glucose uptake.
- 436 W→A: Reduces D-glucose and D-fructose transport activity.
- 439 A→N: Reduces D-glucose and D-fructose transport activity.
- 447 D→A: Reduces susceptibility to inhibition by compound HTI-1; when associated with A-51.
Q9Y7Q9 Probable metabolite transporter C2H8.02 from Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast) (see paper)
29% identity, 36% coverage: 68:231/451 of query aligns to 91:254/583 of Q9Y7Q9
Sites not aligning to the query:
- 267 modified: Phosphoserine
- 269 modified: Phosphoserine
- 289 modified: Phosphoserine
- 290 modified: Phosphoserine
- 292 modified: Phosphoserine
- 330 modified: Phosphoserine
8et8A Cryo-em structure of the organic cation transporter 1 in complex with verapamil (see paper)
23% identity, 83% coverage: 75:447/451 of query aligns to 160:518/532 of 8et8A
- binding (2S)-2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile: K213 (≠ G136), W216 (= W139), Q240 (= Q163), W353 (≠ M270), Y360 (= Y277), F378 (≠ L303), S381 (≠ G306), E385 (≠ V308), C449 (≠ G374), S469 (≠ Y394)
Sites not aligning to the query:
8et7A Cryo-em structure of the organic cation transporter 1 in complex with diphenhydramine (see paper)
23% identity, 83% coverage: 75:447/451 of query aligns to 160:518/532 of 8et7A
Sites not aligning to the query:
6m20B Crystal structure of plasmodium falciparum hexose transporter pfht1 bound with glucose (see paper)
24% identity, 76% coverage: 53:393/451 of query aligns to 50:410/478 of 6m20B
8jttA Hoct1 in complex with metformin in outward occluded conformation (see paper)
24% identity, 77% coverage: 76:423/451 of query aligns to 84:420/454 of 8jttA